Big Pharma – Process AI – Digital Twin
The high cost and time required for manufacturing biologics are significant challenges. However, even a 5% improvement in batch quality can result in substantial cost savings and faster time-to-market, highlighting the importance of continuous improvements in manufacturing processes.